Global Platinum-based Cancer Drug Market is Anticipated to Reach USD 1870 Million at a Robust CAGR of 3% Between 2023 to 2030 | Infinium Global Research

Infinium Global Research, a leading market intelligence firm, has unveiled a comprehensive report on the Global Platinum-based Cancer Drug Market. The report provides a detailed analysis of segments and sub-segments within the global and regional markets, shedding light on the impact of drivers, restraints, and macro indicators in both short and long-term perspectives.

Market Insights:

Valued at USD 1420 million in 2022, the global platinum-based cancer drug market is poised to reach USD 1870 million by 2030, exhibiting a steady CAGR of 3% during the forecast period from 2023 to 2030.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/495

Platinum-based drugs, containing coordinated complexes of platinum, serve as crucial chemotherapeutic agents in cancer treatment, damaging cancerous cells. These drugs, utilized alone or in combination with other treatments, cater to 10% to 20% of chemotherapy patients. The escalating prevalence of cancer, expected to reach 23.6 million cases annually by 2030 according to the National Cancer Institute, stands as a significant driver for this market. However, side effects and drug resistance pose as major restraints.

Recent trends in platinum-based drugs involve the development of analogs with carrier molecules to enhance targeted drug concentration in tumors, reflecting ongoing advancements in this sector.

Market Dynamics:

The increasing concern over high cancer-related mortality rates, aided by government and NGO support, promotes cancer care, fostering the demand for platinum-based treatment therapies. Research and development focused on enhancing drug concentration present abundant market opportunities. Variants such as Carboplatin, Cisplatin, Oxaliplatin, among others, are driving market growth in treating cancers like lung and brain cancer.

Despite growth prospects, the side effects of platinum-based drugs, particularly in chemotherapy, remain a significant concern, including kidney toxicity and nausea. Carboplatin, relatively, exhibits fewer adverse effects, but overall concerns continue to impact market expansion.

Regional Analysis:

The platinum-based cancer drug market is segmented across North America, Europe, Asia Pacific, and the Middle East & Africa. North America holds a substantial market share, attributed to advancements, recent FDA approvals, and significant investments in R&D. Similarly, Europe sees growth owing to increased patients, R&D investments, and advanced research centers. The Asia Pacific region is projected to witness the highest CAGR due to rising disease prevalence, enhanced awareness, and improved healthcare infrastructure.

Segment Coverage:

The report covers segments such as type, application, and distribution channel. Types include cisplatin, oxaliplatin, carboplatin, and others. Applications span colorectal cancer, ovarian cancer, lung cancer, among others. Distribution channels encompass hospital-based pharmacies, retail pharmacies, and online platforms.

Companies Profiled:

Profiles of key market players, including Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sanofi, Eli Lilly and Company, Accord Healthcare, Guizhou Yibai Pharmaceutical Co., Ltd., Bayer AG, Qilu Pharmaceutical Co., Ltd., and Dr. Reddy's Laboratories Ltd., are presented in the report.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/495

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Platinum Based Cancer Drug Market Highlights

2.2. Platinum Based Cancer Drug Market Projection

2.3. Platinum Based Cancer Drug Market Regional Highlights

Chapter 3. Global Platinum Based Cancer Drug Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Type

3.4.2. IGR-Growth Matrix Analysis by Application

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Platinum Based Cancer Drug Market

Chapter 4. Platinum Based Cancer Drug Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Platinum Based Cancer Drug Market

5.2. Companies Profiles

5.2.1. Novartis AG

5.2.2. Teva Pharmaceutical Industries Ltd.

5.2.3. Pfizer Inc.

5.2.4. Sanofi

5.2.5. Eli Lilly and Company

5.2.6. Accord Healthcare

5.2.7. Guizhou Yibai Pharmaceutical Co., Ltd.

5.2.8. Bayer AG

5.2.9. Qilu Pharmaceutical Co., Ltd.

5.2.10. Dr. Reddy's Laboratories Ltd.

Chapter 6. Global Platinum Based Cancer Drug Market by Type

6.1. Cisplatin

6.2. Oxaliplatin

6.3. Carboplatin

6.4. Others

Chapter 7. Global Platinum Based Cancer Drug Market by Application

7.1. Colorectal Cancer

7.2. Ovarian Cancer

7.3. Lung Cancer

7.4. Others

Chapter 8. Global Platinum Based Cancer Drug Market by Distribution Channel

8.1. Hospital-based Pharmacies

8.2. Retail Pharmacies

8.3. Online Pharmacies

Chapter 9. Global Platinum Based Cancer Drug Market by Region 2023-2030

9.1. North America

9.1.1. North America Platinum Based Cancer Drug Market by Type

9.1.2. North America Platinum Based Cancer Drug Market by Application

9.1.3. North America Platinum Based Cancer Drug Market by Distribution Channel

9.1.4. North America Platinum Based Cancer Drug Market by Country

9.1.4.1. The U.S. Platinum Based Cancer Drug Market

9.1.4.1.1. The U.S. Platinum Based Cancer Drug Market by Type

9.1.4.1.2. The U.S. Platinum Based Cancer Drug Market by Application

9.1.4.1.3. The U.S. Platinum Based Cancer Drug Market by Distribution Channel

9.1.4.2. Canada Platinum Based Cancer Drug Market

9.1.4.2.1. Canada Platinum Based Cancer Drug Market by Type

9.1.4.2.2. Canada Platinum Based Cancer Drug Market by Application

9.1.4.2.3. Canada Platinum Based Cancer Drug Market by Distribution Channel

9.1.4.3. Mexico Platinum Based Cancer Drug Market

9.1.4.3.1. Mexico Platinum Based Cancer Drug Market by Type

9.1.4.3.2. Mexico Platinum Based Cancer Drug Market by Application

9.1.4.3.3. Mexico Platinum Based Cancer Drug Market by Distribution Channel

9.2. Europe

9.2.1. Europe Platinum Based Cancer Drug Market by Type

9.2.2. Europe Platinum Based Cancer Drug Market by Application

9.2.3. Europe Platinum Based Cancer Drug Market by Distribution Channel

9.2.4. Europe Platinum Based Cancer Drug Market by Country

9.2.4.1. Germany Platinum Based Cancer Drug Market

9.2.4.1.1. Germany Platinum Based Cancer Drug Market by Type

9.2.4.1.2. Germany Platinum Based Cancer Drug Market by Application

9.2.4.1.3. Germany Platinum Based Cancer Drug Market by Distribution Channel

9.2.4.2. United Kingdom Platinum Based Cancer Drug Market

9.2.4.2.1. United Kingdom Platinum Based Cancer Drug Market by Type

9.2.4.2.2. United Kingdom Platinum Based Cancer Drug Market by Application

9.2.4.2.3. United Kingdom Platinum Based Cancer Drug Market by Distribution Channel

9.2.4.3. France Platinum Based Cancer Drug Market

9.2.4.3.1. France Platinum Based Cancer Drug Market by Type

9.2.4.3.2. France Platinum Based Cancer Drug Market by Application

9.2.4.3.3. France Platinum Based Cancer Drug Market by Distribution Channel

9.2.4.4. Italy Platinum Based Cancer Drug Market

9.2.4.4.1. Italy Platinum Based Cancer Drug Market by Type

9.2.4.4.2. Italy Platinum Based Cancer Drug Market by Application

9.2.4.4.3. Italy Platinum Based Cancer Drug Market by Distribution Channel

9.2.4.5. Rest of Europe Platinum Based Cancer Drug Market

9.2.4.5.1. Rest of Europe Platinum Based Cancer Drug Market by Type

9.2.4.5.2. Rest of Europe Platinum Based Cancer Drug Market by Application

9.2.4.5.3. Rest of Europe Platinum Based Cancer Drug Market by Distribution Channel

9.3. Asia Pacific

9.3.1. Asia Pacific Platinum Based Cancer Drug Market by Type

9.3.2. Asia Pacific Platinum Based Cancer Drug Market by Application

9.3.3. Asia Pacific Platinum Based Cancer Drug Market by Distribution Channel

9.3.4. Asia Pacific Platinum Based Cancer Drug Market by Country

9.3.4.1. China Platinum Based Cancer Drug Market

9.3.4.1.1. China Platinum Based Cancer Drug Market by Type

9.3.4.1.2. China Platinum Based Cancer Drug Market by Application

9.3.4.1.3. China Platinum Based Cancer Drug Market by Distribution Channel

9.3.4.2. Japan Platinum Based Cancer Drug Market

9.3.4.2.1. Japan Platinum Based Cancer Drug Market by Type

9.3.4.2.2. Japan Platinum Based Cancer Drug Market by Application

9.3.4.2.3. Japan Platinum Based Cancer Drug Market by Distribution Channel

9.3.4.3. India Platinum Based Cancer Drug Market

9.3.4.3.1. India Platinum Based Cancer Drug Market by Type

9.3.4.3.2. India Platinum Based Cancer Drug Market by Application

9.3.4.3.3. India Platinum Based Cancer Drug Market by Distribution Channel

9.3.4.4. South Korea Platinum Based Cancer Drug Market

9.3.4.4.1. South Korea Platinum Based Cancer Drug Market by Type

9.3.4.4.2. South Korea Platinum Based Cancer Drug Market by Application

9.3.4.4.3. South Korea Platinum Based Cancer Drug Market by Distribution Channel

9.3.4.5. Australia Platinum Based Cancer Drug Market

9.3.4.5.1. Australia Platinum Based Cancer Drug Market by Type

9.3.4.5.2. Australia Platinum Based Cancer Drug Market by Application

9.3.4.5.3. Australia Platinum Based Cancer Drug Market by Distribution Channel

9.3.4.6. Rest of Asia-Pacific Platinum Based Cancer Drug Market

9.3.4.6.1. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Type

9.3.4.6.2. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Application

9.3.4.6.3. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Distribution Channel

9.4. RoW

9.4.1. RoW Platinum Based Cancer Drug Market by Type

9.4.2. RoW Platinum Based Cancer Drug Market by Application

9.4.3. RoW Platinum Based Cancer Drug Market by Distribution Channel

9.4.4. RoW Platinum Based Cancer Drug Market by Sub-region

9.4.4.1. Latin America Platinum Based Cancer Drug Market

9.4.4.1.1. Latin America Platinum Based Cancer Drug Market by Type

9.4.4.1.2. Latin America Platinum Based Cancer Drug Market by Application

9.4.4.1.3. Latin America Platinum Based Cancer Drug Market by Distribution Channel

9.4.4.2. Middle East Platinum Based Cancer Drug Market

9.4.4.2.1. Middle East Platinum Based Cancer Drug Market by Type

9.4.4.2.2. Middle East Platinum Based Cancer Drug Market by Application

9.4.4.2.3. Middle East Platinum Based Cancer Drug Market by Distribution Channel

9.4.4.3. Africa Platinum Based Cancer Drug Market

9.4.4.3.1. Africa Platinum Based Cancer Drug Market by Type

9.4.4.3.2. Africa Platinum Based Cancer Drug Market by Application

9.4.4.3.3. Africa Platinum Based Cancer Drug Market by Distribution Channel

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/495

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of platinum-based cancer drug.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.